Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 May 1;187(9):1030.
doi: 10.1164/rccm.201211-2060LE.

Reply: A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?

Comment

Reply: A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?

Imre Noth et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA. Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet) A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 2012;186:88–95. - PMC - PubMed
    1. Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, Sasaki H. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest . 2005;128:1475–1482. - PubMed
    1. Nakashima T, Yokoyama A, Inata J, Ishikawa N, Haruta Y, Hattori N, Kohno N. Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS. Chest . 2011;139:296–304. - PubMed
    1. Vij R, Noth I. Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl Res . 2012;159:218–227. - PMC - PubMed
    1. Noth I, Olman MA. Reply: Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis? [letter] Am J Respir Crit Care Med . 2012;186:693–694. - PMC - PubMed

LinkOut - more resources